| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |